Who owns OTLK?
Institutional ownership of Outlook Therapeutics Inc. from Form 13F, Q2 2026
69 institutional managers reported holding Outlook Therapeutics Inc. (OTLK) in Form 13F filings for Q2 2026, with 20,453,279 shares worth $32.5M. The largest reported holder was Vanguard Capital Management LLC. Managers that filed both quarters added a net 9,721,853 shares (+90.6%). 27 opened new positions and 13 sold out.
- Funds holding
- 69
- Value held
- $32.5M
- New / sold out
- 27 / 13
- Net shares, same filers
- +90.6%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of OTLK
Share of 13F holdings is each fund's shares as a share of the 20,453,279 OTLK shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Perceptive Advisors LLC New+$5.0M
- Vanguard Capital Management LLC Added+$3.8M
- Marshall Wace, LLP New+$3.2M
- Jane Street Group, LLC New+$2.3M
- BlackRock, Inc. Added+$1.9M
- Susquehanna International Group, LLP Added+$1.3M
- HRT Financial LP Added+$1.1M
- Geode Capital Management, LLC Added+$1.0M
- Vanguard Fiduciary Trust Co Added+$771K
- Cantor Fitzgerald, L. P. New+$716K
Biggest sellers in Q2 2026
- Armistice Capital, LLC Sold out-$858K
- Commonwealth Equity Services, LLC Sold out-$97K
- Gilpin Wealth Management, LLC Trimmed-$72K
- Warberg Asset Management LLC Sold out-$56K
- Renaissance Technologies LLC Sold out-$53K
- NINE MASTS CAPITAL Ltd Sold out-$48K
- Connective Capital Management, LLC Sold out-$41K
- Virtu Financial LLC Sold out-$23K
- Vanguard Personalized Indexing Management, LLC Trimmed-$12K
- XTX Topco Ltd Sold out-$11K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $24.8M and sold $1.3M; 20 added and 7 trimmed.
Schedule 13D and 13G filings on OTLK
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-10-13Empery Asset Management, LP SCHEDULE 13G filed by Outlook Therapeutics Inc.Schedule 13G
- 2026-08-19CVI Investments, Inc. SCHEDULE 13G filed by Outlook Therapeutics Inc.Schedule 13G
- 2026-04-24INTRACOASTAL CAPITAL, LLC SCHEDULE 13G filed by Outlook Therapeutics Inc.Schedule 13G
- 2025-07-31Empery Asset Management, LP SCHEDULE 13G filed by Outlook Therapeutics Inc.Schedule 13G
- 2025-03-03SPHERA FUNDS MANAGEMENT LTD. SCHEDULE 13G filed by Outlook Therapeutics Inc.Schedule 13G
Questions about OTLK ownership
- Who owns OTLK stock?
- 69 institutional investment managers reported OTLK positions in their Form 13F filings for Q2 2026, holding 20,453,279 shares worth $32.5M in total. Vanguard Capital Management LLC reported the largest position.
- Are funds buying or selling OTLK?
- In Q2 2026, 27 managers opened new OTLK positions, 20 added, 7 trimmed and 13 sold out. Managers that filed in both quarters added a net 9,721,853 shares.
- How current is this OTLK institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to OTLK by CUSIP. Options are left out. OTLK news and filings · OTLK insider trades · Top funds